Medicine
Telmisartan 80 mg tablet
Telmisartan 80 mg tablet is a generic prescription medicine for oral use, made by 23 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C…
Key facts
- Active ingredient (INN)
- Telmisartan
- Brand
- Sold under the generic name
- Strength
- 80 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets, 1000 tablets, 100 tablets and 78 more
- Manufacturers
- Zydus LifesciencesIndiaCadila PharmaceuticalsIndiaGlenmark PharmaceuticalsIndiaAlembic PharmaceuticalsIndiaAscend LaboratoriesIndiaAurobindo PharmaIndiaLifestar PharmaIndiaMacleods PharmaceuticalsIndiaJubilant Cadista PharmaceuticalsIndiaAmneal Pharmaceuticals23 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C09CA07 Telmisartan
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 31 May 2013
- Identifiers
- RxCUI 205304, 205305, 282755DailyMed set ID bf2dca37-ce9c-40e4-8ad6-b8186aa7fed1, e1a907a7-fad9-a860-8639-4c6136c85734, 3f021f06-99df-48d1-e063-6394a90a8d0f +28NDC 53746-293, 59746-441, 68071-3892 +28Application ANDA204415, ANDA204164, ANDA207882 +10
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 23 labelers. The register lists 81 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet in 1 bottle | 46708-610-30 | Alembic PharmaceuticalsIndia | 25 June 2016 |
| 1000 tablet in 1 bottle | 46708-610-91 | Alembic PharmaceuticalsIndia | 25 June 2016 |
| 30 tablet in 1 bottle | 62332-089-30 | Alembic PharmaceuticalsIndia | 25 June 2016 |
| 1000 tablet in 1 bottle | 62332-089-91 | Alembic PharmaceuticalsIndia | 25 June 2016 |
| 100 tablet in 1 bottle | 65841-806-01 | Zydus LifesciencesIndia | 27 August 2014 |
| 500 tablet in 1 bottle | 65841-806-05 | Zydus LifesciencesIndia | 27 August 2014 |
| 30 tablet in 1 bottle | 65841-806-06 | Zydus LifesciencesIndia | 27 August 2014 |
| 1000 tablet in 1 bottle | 65841-806-10 | Zydus LifesciencesIndia | 27 August 2014 |
| 90 tablet in 1 bottle | 65841-806-16 | Zydus LifesciencesIndia | 27 August 2014 |
| 30 blister pack in 1 carton / 1 tablet in 1 blister pack | 65841-806-78 | Zydus LifesciencesIndia | 27 August 2014 |
| 100 tablet in 1 bottle | 68382-473-01 | Zydus LifesciencesIndia | 27 August 2014 |
| 500 tablet in 1 bottle | 68382-473-05 | Zydus LifesciencesIndia | 27 August 2014 |
| 30 tablet in 1 bottle | 68382-473-06 | Zydus LifesciencesIndia | 27 August 2014 |
| 1000 tablet in 1 bottle | 68382-473-10 | Zydus LifesciencesIndia | 27 August 2014 |
| 90 tablet in 1 bottle | 68382-473-16 | Zydus LifesciencesIndia | 27 August 2014 |
| 30 blister pack in 1 carton / 1 tablet in 1 blister pack | 68382-473-78 | Zydus LifesciencesIndia | 27 August 2014 |
| 500 tablet in 1 bottle | 67877-484-05 | Ascend LaboratoriesIndia | 25 July 2019 |
| 30 tablet in 1 bottle | 67877-484-30 | Ascend LaboratoriesIndia | 25 July 2019 |
| 90 tablet in 1 bottle | 67877-484-90 | Ascend LaboratoriesIndia | 25 July 2019 |
| 3 blister pack in 1 carton / 10 tablet in 1 blister pack | 65862-869-03 | Aurobindo PharmaIndia | 3 September 2015 |
| 30 tablet in 1 bottle | 65862-869-30 | Aurobindo PharmaIndia | 3 June 2019 |
| 30 tablet in 1 bottle | 71209-051-01 | Cadila PharmaceuticalsIndia | 22 December 2022 |
| 90 tablet in 1 bottle | 71209-051-04 | Cadila PharmaceuticalsIndia | 22 December 2022 |
| 100 tablet in 1 bottle | 71209-051-05 | Cadila PharmaceuticalsIndia | 22 December 2022 |
| 500 tablet in 1 bottle | 71209-051-10 | Cadila PharmaceuticalsIndia | 22 December 2022 |
| 1000 tablet in 1 bottle | 71209-051-11 | Cadila PharmaceuticalsIndia | 22 December 2022 |
| 30 blister pack in 1 carton / 10 tablet in 1 blister pack | 71209-051-16 | Cadila PharmaceuticalsIndia | 5 February 2015 |
| 30 blister pack in 1 carton / 10 tablet in 1 blister pack | 71209-051-18 | Cadila PharmaceuticalsIndia | 5 February 2015 |
| 100 tablet in 1 bottle | 68462-201-01 | Glenmark PharmaceuticalsIndia | 7 July 2014 |
| 3 blister pack in 1 carton / 10 tablet in 1 blister pack | 68462-201-13 | Glenmark PharmaceuticalsIndia | 7 July 2014 |
| 30 tablet in 1 bottle | 68462-201-30 | Glenmark PharmaceuticalsIndia | 14 December 2020 |
| 4 blister pack in 1 carton / 10 tablet in 1 blister pack | 68462-201-78 | Glenmark PharmaceuticalsIndia | 14 December 2020 |
| 90 tablet in 1 bottle | 68462-201-90 | Glenmark PharmaceuticalsIndia | 7 March 2024 |
| 3 blister pack in 1 carton / 10 tablet in 1 blister pack | 59746-441-32 | Jubilant Cadista PharmacuticalsIndia | 22 August 2016 |
| 30 tablet in 1 bottle | 70756-314-30 | Lifestar PharmaIndia | 15 October 2024 |
| 8 blister pack in 1 carton / 10 tablet in 1 blister pack | 70756-314-80 | Lifestar PharmaIndia | 15 October 2024 |
| 30 tablet in 1 container | 33342-120-07 | Macleods PharmaceuticalsIndia | 15 January 2025 |
| 90 tablet in 1 container | 33342-120-10 | Macleods PharmaceuticalsIndia | 15 January 2025 |
| 30 tablet in 1 bottle | 65162-293-03 | Amneal Pharmaceuticals | 31 May 2013 |
| 90 tablet in 1 bottle | 65162-293-09 | Amneal Pharmaceuticals | 31 May 2013 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Telmisartan
Clinical summary
Telmisartan is an angiotensin 2 receptor blocker indicated for treatment of hypertension to lower blood pressure. It is available as tablets for oral use. MedsAcross supplies Telmisartan for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about TelmisartanFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Telmisartan prescribing information (Alembic Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Micardis: European public assessment report (EPAR) · European Medicines Agency
- Telmisartan Actavis: European public assessment report (EPAR) · European Medicines Agency
Need Telmisartan 80 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.